about
Quality of life in patients with vitiligoMechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Evaluation of the serum zinc level in patients with vitiligo.CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.Association of CYP2C9 Genetic Variants with Vitiligo.Evaluation of Histologically and Histochemically Proven Cases of Vitiligo and its Correlation with CD4+ and CD8+ Lymphocyte Counts using Flow Cytometry.A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.Acute toxicity and the 28-day repeated dose study of a Siddha medicine Nuna Kadugu in rats.Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control studyEpidemiological pattern of psoriasis, vitiligo and atopic dermatitis in India: Hospital-based point prevalence.The Koebner phenomenon: review of the literature.Anti-thyroid peroxidase antibody in vitiligo: a prevalence study.Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses.Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.The vitiligo in senegal.When are laboratory tests indicated in patients with vitiligo?The Prevalence of Vitiligo: A Meta-Analysis.Vitiligo presentation in adults.Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening.Study of oxidative stress in peripheral blood of Indian vitiligo patients.Gender differences in clinicoepidemiological features of vitiligo: a cross-sectional analysis.Profile of vitiligo in kumaun region of uttarakhand, India.Vitiligo, reactive oxygen species and T-cells.The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review.The prevalence of thyroid disease in patients with vitiligo: a systematic review.Profile of vitiligo in the south of Tunisia.Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin).Inhibitory and Acceleratory Effects of Inonotus obliquus on Tyrosinase Activity and Melanin Formation in B16 Melanoma CellsChildhood vitiligo: treatment paradigms.Oxidative stress in experimental vitiligo C57BL/6 mice.An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children.Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo.The 'EpiEnlist' project: a dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions.Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients.Study on the antioxidant status of vitiligo patients of different age groups in Baroda.Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo.Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries.Comprehensive survey of vitiligo patients in the northeast of China using a predesigned questionnaire.
P2860
Q24642322-BC7C609F-CB66-447E-A369-F053AFA9E445Q30433217-73D2D3C0-09A7-4D7F-AD7B-20E65CB5B8B0Q33645847-9E4F374D-4EB8-4CCE-A89F-F5A01C45599FQ33796655-6F926FF2-9360-4505-9D24-BC91B267D00DQ33801991-6A4EC5C3-72C9-4D2C-A57B-C05836F569DEQ33831895-17A2E5C3-B43F-43E1-9AB5-BD9C983955F4Q33897820-F068010F-E1C5-4D67-AADC-655EB1D983FCQ34110126-AEEBC3AB-6814-4CA0-A530-B6104F078B79Q34307517-1CB22935-9314-447B-8391-67F2B12E0B0FQ34494983-2F8EDB24-9E40-4BDA-94DB-D288FAD2557EQ34616899-089473E4-BB05-4FF8-B1AE-905E6F2F99F2Q34796403-83DB76D0-5CD2-4300-8681-64A895F88371Q35012290-97D53CE0-3FDD-4A09-A157-FC91AEDCE52FQ35202222-287CA41A-3AE6-4EE1-87F5-2B18434D49E5Q35656082-2F092E06-A817-45C8-8076-0EB58315413EQ35692074-459D1157-5B46-436F-AC2F-69B434F2AFBBQ36130025-6DB98820-C72C-458C-8113-616307A322E1Q36145882-6C2E98B7-0E71-42AF-B2CB-37C5CBC631A0Q36161409-1719958E-4349-439D-86E7-0D8B11322183Q36767147-0877AA22-4648-4831-89C4-7BEB1C294F3DQ37322584-DEA5157C-BB60-4998-A693-75A649C4E752Q37370107-FE1D896E-732D-4E26-B8A6-B86C060685FCQ37627068-AC047606-2452-4B1E-9770-B66A9963B26CQ37672234-E501E8B6-8F57-46C9-B13B-E63852BC65A8Q37801388-CDA39277-1857-43C8-977A-C647EB800EFFQ38030614-77BCFA05-2EC8-4E8A-ADC9-E30D1BAA1F00Q38031886-46013FB9-E7C8-4664-9403-77F4C4C1B622Q38865494-716DDDDF-4F84-436D-8BE4-1E51E8137A45Q40563763-9BDE38FB-F0AD-46C3-BE36-558848D5F4ADQ41903684-0B228F93-C89A-4319-A290-E1D8014ED1ABQ42183458-B0C731AC-FBD2-4BCB-AE17-5FEB054F2AECQ42232051-5C5632E9-3517-4EDE-860A-29E4D356D941Q43252688-134FC984-F0C6-4934-BF8C-19198F2E9F0AQ43494518-222902F8-0C46-44F9-BF6F-53E99EEF8002Q43680400-73F7EE4E-D3B4-4DAD-91E2-33EA1307A0CCQ43768391-7C7E751D-CAF4-47DD-B0A6-4A957C07683BQ44893860-83F1BA7E-478B-4366-9726-318E728E9890Q46252903-CE8D1694-2799-4E7B-A426-77D85F70D86EQ46953146-189E5861-946A-49DD-8517-CD76E2757B7FQ47630381-4AF95A06-0973-4B57-A78F-F683C3D2F717
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Vitiligo: clinical findings in 1436 patients.
@en
Vitiligo: clinical findings in 1436 patients.
@nl
type
label
Vitiligo: clinical findings in 1436 patients.
@en
Vitiligo: clinical findings in 1436 patients.
@nl
prefLabel
Vitiligo: clinical findings in 1436 patients.
@en
Vitiligo: clinical findings in 1436 patients.
@nl
P2860
P1476
Vitiligo: clinical findings in 1436 patients.
@en
P2860
P304
P356
10.1111/J.1346-8138.1999.TB02067.X
P577
1999-10-01T00:00:00Z